Trial Site Detail
Drug: |
Masitinib, (AB1010) |
|||
|---|---|---|---|---|
Trial: |
Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancers |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Completed |
|||
Institut Bergonie229 Cours Argonne |
Principal Investigator: |
Binh Bui Nguyen, MD |
|---|---|
Contact: |
|
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Institut Bergonie Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.